SCHEMBL23635941

SCHEMBL23635941

CCc1nc(NC(C)=O)no1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.39
ALPL P05186 2/20 0.39
POLB P06746 3/20 0.39
CCNE2 O96020 2/20 0.37
CCNE1 P24864 2/20 0.37
CDK2 P24941 2/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
ALOX15 P16050 1/20 0.35
APOBEC3A P31941 1/20 0.35
HSD17B10 Q99714 1/20 0.35
APOBEC3G Q9HC16 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ADORA3 P0DMS8 2/20 0.34
ADORA1 P30542 1/20 0.34
RAB9A P51151 3/20 0.33
NPC1 O15118 2/20 0.33
ALDH1A1 P00352 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21889279 0.81 AOC3 (0.40) KDM4EPOLBCCNE2CCNE1CDK2
SCHEMBL23631838 0.75 LMNA (0.44) KDM4EALPLPOLBCYP1A2CYP2C9
SCHEMBL7263917 0.68 HSD17B10 (0.42) KDM4EALOX15APOBEC3AHSD17B10APOBEC3G
SCHEMBL3299561 0.67 POLB (0.62) KDM4EALPLPOLBCYP1A2CYP2C9
SCHEMBL10806751 0.66 CA2 (0.44) KDM4ECYP1A2HSD17B10L3MBTL1RAB9A
SCHEMBL11540720 0.66 CCNE2 (0.48) KDM4EPOLBCCNE2CCNE1CDK2
SCHEMBL15305663 0.65 POLB (0.46) KDM4EALPLPOLBCYP1A2CYP2C9
SCHEMBL6124859 0.65
SCHEMBL18141918 0.64 APOBEC3A (0.54) KDM4EPOLBCYP1A2CYP2C19ALOX15
SCHEMBL11294168 0.63 NPC1 (0.47) L3MBTL1RAB9ANPC1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11911372-B2 Compounds CTXT PTY LTD (AU) 2024-02-27 US disclosed
US-20210213004-A1 Compounds CTXT PTY LTD (AU) 2021-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210213004-A1 Compounds SLC10A1, ABCB11, REN KDM4E 3932/4885ALPL 1275/4885POLB 4295/4885
US-11911372-B2 Compounds SLC10A1, ABCB11, REN KDM4E 3932/4885ALPL 1275/4885POLB 4295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.